Jean‐Claude Roujeau

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

Maja Mockenhaupt, Cécile Viboud, Ariane Dunant et al. · Journal of Investigative Dermatology · 2007 · 998 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Christine Lonjou, Nicolas Borot, Peggy Sekula et al. · Pharmacogenetics and Genomics · 2008 · 621 citations

Medicine, Pharmacology, Pharmacotherapy +14

A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid

P. Joly, Jean‐Claude Roujeau, Jacques Bénichou et al. · New England Journal of Medicine · 2002 · 617 citations

Medicine, Dermatology, Pharmacotherapy +17

Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis

Ariane Auquier-Dunant, Maja Mockenhaupt, Luigi Naldi et al. · Archives of Dermatology · 2002 · 615 citations

Medicine, Dermatology, Internal Medicine +13

Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

I. García‐Doval, Laurence Le Cleach, Hélène Bocquet et al. · Archives of Dermatology · 2000 · 493 citations

Medicine, Dermatology, Clinical Epidemiology +6